The use of commercial nuclear reactors for Lutetium-177 production provides a diverse, agile, and scalable solution that can meet the world’s growing demand.
The use of commercial nuclear reactors for Lutetium-177 production provides a diverse, agile, and scalable solution that can meet the world’s growing demand.
The digital flux mapping system (FMS), a foundational technology for radioisotope production, resolves parts obsolescence concerns and is more reliable, more efficient, and easier to use compared to the outdated MIDS.
Innovative technologies that integrate seamlessly with the digital FMS can be used to produce short half-life radioisotopes while commercial plants are online, with no disruptions to safe power generation.
The production of Lutetium-177 provides attractive social license and a significant annual revenue stream to host utilities that can be used to offset O&M costs and improve the cost-competitiveness of nuclear.
over
100
commercial nuclear reactors globally that can be used for production of Lutetium-177 and other radioisotopes
more than
30%
of forecasted future demand can be produced by a single commercial nuclear reactor with sufficient target material
can add another
40 years
of continued operation
upwards of
25
radioisotopes, including Lutetium-177, can be produced using the digital flux mapping system
$500K-$2.5M
per year additional revenue for a host reactor and potentially higher with other isotope developments
Please rotate your device.
This site can be viewed in landscape mode on mobile devices or on any computer.